The Trond Mohn Foundation is joining forces with the University of Bergen and Haukeland University Hospital to provide NOK 52 million in funding over the next five years. […]

Read More…

Antimicrobial resistance (AMR) is a top threat to global health according to the World Health Organization (WHO), with a current count of 700,000 annual deaths, predicted to rise to 10 million and pose a 100 trillion USD economic burden by 2050. […]

Read More…

The funding from the Trond Mohn Foundation will give researchers in Bergen the opportunity to develop new ways of treating chronic and acute wounds, bone damage and psychosis using stem cells.

Etableringen av et nytt senter for regenerativ medisin og forskningen ved dette senteret, vil komme en rekke pasientgrupper til gode. […]

Read More…

Trond Mohn stiftelse har tildelt 16 millioner kroner til Senter for dyphavsforskning ved Universitetet i Bergen (UiB) fordelt over fem år. UiB avsetter ca 88 millioner kroner til lønnsmidler og drift av det tverrfaglige forskningssenteret. […]

Read More…

Det nyetablerte senter for regenerativ medisin skal nominere prosjekter til Trond Mohn stiftelse. […]

Read More…

The Research Council, the Norwegian Cancer Society and Trond Mohn Foundation will organize a seminar series in the period 2020–2022. […]

Read More…

Information about the Foundation’s policies on issues arising from the corona situation. […]

Read More…

The foundation’s first Newsletter was published November 20th. […]

Read More…